Pulmonary zygomycosis - A rare angioinvasive fungal infection;Pulmonale zygomykose - Eine seltene angioinvasive pilzinfektion

Mycoses, Supplement

Volumn 48, Issue 1, 2005, Pages 99-107

  Lewejohann, Jan Christoph ^a   Muhl, Elke ^a   Birth, M ^a   Kujath, P ^a   Bruch, H P ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Lungs; Rhizopus; Zygomycosis

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; CASE REPORT; CONFERENCE PAPER; FEMALE; FEMOROPOPLITEAL BYPASS; HIP ARTHROPLASTY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; LUNG INFECTION; LUNG LAVAGE; LUNG RESECTION; MALE; MORTALITY; MUCORMYCOSIS; OPPORTUNISTIC INFECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; RARE DISEASE; RHIZOPUS; SEPSIS;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; MALE; MUCORMYCOSIS; RHIZOPUS;

EID: 17844385073     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
2. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247-51.
3. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-55.
4. Rubin RH. The compromised host as sentienel chicken [editorial]. N Engl J Med 1987; 317: 1151-3.
5. Flanagan PG, Barnes RA. Fungal infection in the intensive care unit. J Hosp Infect 1998; 38: 163-77.
6. Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000; 15: 83-90.
7. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson JE, Rinaldi M. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253-8.
8. Guardia JA, Bourgoignie J, Diego J. Renal mucormycosis in the HIV patient. Amer J Kidney Dis 2000; 35: E241-5.
9. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KVI. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30: 851-6.
10. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 1989; 11: 741-54.
11. Ribes J, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
12. Chen KY, Ko SC, Hsueh PR, Luh KT, Yang PC. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome and prognostic factors. Chest 2001; 120: 177-84.
13. Morrison VA, Mc Glave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993; 11: 383-8.
14. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant patient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995; 20: 617-20.
15. Maury S, Leblanc T, Feuihade M, Molina JM, Schaison G. Successful treatment of disseminated mucormycosis with liposomal amphotericin B and surgery in a child with leukemia. Clin Infect Dis 1998; 26: 200-2.
16. Chakrabati A, Das A, Sharma A, Pamda N, Das S, Gupta KL. Ten years' experience in zygomycosis at a tertiary centre in India. J Infect 2001; 42: 261-6.
17. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
18. Eisen DP, Robson J. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygmycosis. Mycoses 2004; 47: 159-62.
19. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE and the Eurofung Network. In vitro susceptibilities of Zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52.
20. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, PA: Lea & Febiger, 1992.
21. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40-79.
22. Penk A, Pittrow L. Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients. Mycoses 1999; 42: 97-100.
23. Perez A. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses 1999; 42: 111-4.
24. Cornely OA, Schmitz K, Aisenbrey S. The first echinocandin: caspofungin. Mycoses 2002; 45 (Suppl. 2): 56-60.
25. Sugar AM, Liu XP. Combination antilungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles. Antimicrob Agents Chemother 2000; 44: 2004-6.
26. Tobon AM, Arango M, Fernandez D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazol therapy. Clin Infect Dis 2003; 36: 1488-91.
27. 7 Barratt DM, van Meter K, Asmar P et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrobial Agents Chemother 2001; 45: 3601-2.
28. Nosari AP, Oreste M, Montillo G et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000; 85: 1068-107.
29. Garcia-Diaz JB, Palau L, Pankey GA. Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor. Clin Infect Dis 2001; 32: e166-70.
30. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: Successful treatment with amphotericin B lipid complex and granuloyte colony-stimulating factor. Clin Infect Dis 1997; 24: 192-6.
31. Mok CC, Que TL, Tsui EY, Lam WY. Mucormycosis in systemic lupus erythematosus. Semin Arthritis Rheum 2003; 33: 115-24.